Two meta-analyses demonstrated a pooled specificity of 93.5–98% and a sensitivity of 67.4–68% for cfDNA, when plasma samples were tested to determine the EGFR mutational status compared with matched tumor tissues [23,25]. This evidence concerns the gene EGFR and neoplasm.